Clinical analysis of ultrasound-guided catheterization in intraperitoneal perfusion chemotherapy for postoperative abdominal malignant tumor without ascites
10.3760/cma.j.issn.1006-9801.2019.04.008
- VernacularTitle:腹腔恶性肿瘤术后无腹腔积液状态下超声引导腹腔置管辅助灌注化疗临床分析
- Author:
Zhongshi DU
1
;
Lina TANG
;
Youhong SHEN
;
Zhougui WU
;
Weiqin HUANG
;
Yijie CHEN
Author Information
1. 福建省肿瘤医院 福建医科大学附属肿瘤医院超声科
- Keywords:
Chemotherapy;
cancer;
regional perfusion;
Intraperitoneal perfusion chemotherapy;
Catheterization;
Ultrasound
- From:
Cancer Research and Clinic
2019;31(4):250-252
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value of ultrasound-guided catheterization in intraperitoneal perfusion chemotherapy for postoperative abdominal malignant tumor without ascites. Methods A retrospective analysis were performed in 146 postoperative patients with abdominal malignancies who were admitted to Fujian Cancer Hospital from April 2013 to September 2018, and there were no ascites founded in these patients before abdominal catheterization. Two hundred and seventy-nine times ultrasound-guided catheterization in intraperitoneal perfusion chemotherapy were performed under clinical guidance. Results Two hundred and seventy-seven times abdominal catheterization was completed, with a success rate of 99.3％(277/279), and the one-time success rate was 83.2％(232/279), 2 times (0.7％, 2/279) had to be abandoned for peritoneal adhesions. Fifty-three patients (36.3％, 53/146) underwent catheterization ≥ 2 times. The intraperitoneal perfusion chemotherapy was successfully completed after catheterization, no intestinal injury and bleeding occurred. Conclusions In the absence of ascites, ultrasound guided catheterization in perfusion chemotherapy is safe, reliable, simple, accurate and has a high success rate. This new approach is good for clinical application when the conventional catheterization with ascites is blocked.
